Your session is about to expire
← Back to Search
Online Intervention for Gender Dysphoria
N/A
Waitlist Available
Led By Stephanie Budge, PhD, LP
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after intervention (participants will have up to 1 week to complete intervention), 3 month follow up
Awards & highlights
Study Summary
This trial seeks to reduce symptoms of gender dysphoria & improve well-being for trans & nonbinary individuals through an online intervention (Trans Care). A randomized controlled trial will enroll 260 TNB participants.
Who is the study for?
This trial is for transgender, transsexual, nonbinary individuals or those with a transgender history who are experiencing gender dysphoria. Participants need to have the time to commit to a 2-3-hour online intervention and follow-up surveys.Check my eligibility
What is being tested?
The Trans Care Web App is being tested in this study. It's an online program with eight modules designed to reduce symptoms of gender dysphoria, increase active coping skills, and improve overall well-being.See study design
What are the potential side effects?
Since this intervention involves an educational web app rather than medication or medical procedures, traditional physical side effects are not expected. However, emotional discomfort may occur while addressing sensitive topics.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before and after intervention (participants will have up to 1 week to complete intervention), 3 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after intervention (participants will have up to 1 week to complete intervention), 3 month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Depression, Anxiety, and Stress Scale (DASS-21) Score
Change in Gender Congruence and Life Satisfaction Scale (GCLS) Score
Change in Modified Gender Minority Stress and Resilience measure (M-GMSRM) Score
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Trans Care InterventionExperimental Treatment1 Intervention
Group II: Waitlist ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,167,127 Total Patients Enrolled
1 Trials studying Gender Dysphoria
100 Patients Enrolled for Gender Dysphoria
Stephanie Budge, PhD, LPPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Gender Dysphoria
100 Patients Enrolled for Gender Dysphoria
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I identify as transgender, transsexual, nonbinary, or have a transgender history.I can dedicate 3-5 hours for an online intervention and follow-up surveys.I am younger than 18 years old.I do not identify as transgender, transsexual, nonbinary, or have a transgender history.I cannot commit to the study's schedule.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist Control
- Group 2: Trans Care Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability to join this experiment?
"As per clinicaltrials.gov, this research is no longer enrolling patients; the protocol was initially posted on October 1st 2024 and last updated June 5th 2023. Conversely, there are currently 388 other trials that have open recruitment at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger